Sector

Healthcare & Medical

Live opportunities

681

Largest live: £12bn

A high-activity UK & EU sector, led by NHS ENGLAND, most recent listing yesterday.

United Kingdom + 5 moreAvg value £13.6m+28% · 30 days

Clinical services, medical equipment, pharmaceuticals, NHS contracts, and health research.

Live opportunities

681

Largest live: £12bn

Activity, last 12 months

7K published

2025-08Peak: 2026-06 · 1K2026-08

Sector brief

4 fields

Live now
681
Opportunities open today
Total on record
12K
Across all statuses
Total value (£ only)
£157.2bn
Avg £13.6m
30-day momentum
+28%
Last published yesterday

Opportunities

633 on record

Germany

Open-House Model for Certolizumab Pegol Discount Agreements

This contract opportunity involves establishing non-exclusive discount agreements for the medication Certolizumab pegol, as per § 130a Abs. 8 SGB V. The agreements will be made under an Open-House model, allowing all interested pharmaceutical companies to participate during the application period, p

AOK PLUS THE HEALTH FUND FOR SAXONY AND THURINGIA

Published 24 Aug 2025

Germany

Open House Discount Contracts for Rivaroxaban

This contract opportunity involves the establishment of non-exclusive discount contracts for the medication Rivaroxaban, specifically for film-coated tablets excluding the 2.5 mg strength. The contracts will be in effect from October 1, 2025, to September 30, 2027, with the option for suppliers to e

AOK RHEINLANDPFALZSAARLAND THE HEALTH FUND

Published 21 Aug 2025

Germany

Non-Exclusive Discount Agreement for Calcium Carbonate and Colecalciferol

The German health insurance companies and pharmaceutical companies can enter into framework discount agreements for medications covered by statutory health insurance, as permitted by § 130a paragraph 8 of the Social Code Book V. The DAK-Gesundheit will conduct a formal procurement process for the ac

€1nominalDAK HEALTH

Published 19 Aug 2025

Germany

Open House Discount Contracts for Leuprorelin in Germany

This is not a standard procurement process but an open-house model for pharmaceutical companies. The AOK Bayern intends to establish non-exclusive discount agreements for the drug Leuprorelin (ATC L02AE02) with all interested pharmaceutical companies that meet the specified eligibility criteria. The

AOK BAYERN THE HEALTH INSURANCE FUND

Published 13 Aug 2025

Germany

Germany – Pharmaceutical Discounts Framework Agreement

This announcement is for establishing agreements with pharmaceutical companies as per § 130a Abs. 8 Sentence 1 SGB V. The invitation to participate is directed only to pharmaceutical entrepreneurs or associations of pharmaceutical entrepreneurs as defined in § 4 Abs. 18 of the Medicines Act. This is

DEUTSCHE PENSION INSURANCE KNAPPSCHAFTBAHNSEE

Published 10 Aug 2025

Germany

Framework Agreement for Blood Glucose Test Strips in North Rhine-Westphalia

This announcement is for establishing agreements with companies or consortia of companies for blood glucose test strips in accordance with § 130a Abs. 8 Satz 1 of the Fifth Book of the Social Code (SGBV) for the state of North Rhine-Westphalia. The agreements will include discount contracts, allowin

DEUTSCHE PENSION INSURANCE KNAPPSCHAFTBAHNSEE

Published 7 Aug 2025

Germany

Open House Discount Contracts for Olodaterol and Tiotropium Bromide

This contract opportunity involves the establishment of non-exclusive discount contracts for medications containing the active ingredients Olodaterol and Tiotropium Bromide. The contracts will be in effect from October 1, 2025, to September 30, 2027, with the possibility of entering into contracts a

AOK RHEINLANDPFALZSAARLAND THE HEALTH FUND

Published 5 Aug 2025

Germany

Open House Discount Contracts for Tramadol and Paracetamol

This contract opportunity involves the establishment of non-exclusive discount contracts for the pharmaceutical products Tramadol and Paracetamol, in accordance with German social law. The contracts will be valid from October 1, 2025, to September 30, 2027, and suppliers can enter into contracts at

AOK RHEINLANDPFALZSAARLAND THE HEALTH FUND

Published 5 Aug 2025

Germany

Germany – Pharmaceutical Discounts Agreement

The Kaufmännische Krankenkasse (KKH) aims to establish discount agreements with all suitable pharmaceutical companies for the specified active ingredients under Section 130a, Paragraph 8 of the Social Code Book V (SGB V) through an 'Open-House' procedure. This process allows all eligible and interes

KKH COMMERCIAL HEALTH INSURANCE

Published 24 Jul 2025

Germany

Open-House Discount Contracts for Pharmaceuticals in Germany (2025)

The health insurance funds (whether HEK and/or hkk participate in each lot is determined by the designation of the respective lot) aim to establish discount contracts with all suitable pharmaceutical companies according to § 130a Abs. 8 SGB V for the active ingredients, combinations of active ingred

TECHNIKER HEALTH INSURANCE

Published 20 Jul 2025